February 18, 2019 1:06 am PT by Jose Rossello, MD, PhD, MHCM - 0 comments
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 11-14 February 2019 News 15/02/2019 EMA’s safety committee ( PRAC ) has started a review of the risk of QT prolongation and torsades de pointes (abnormalities of the heart’s electrical activity that may lead to heart rhythm disturbances) with fenspiride medicines. Fenspiride is used in children Read more…
August 18, 2012 1:13 am PT by Jose Rossello, MD, PhD, MHCM - 0 comments
About 66% of adults and 33% of children in the United States are overweight or obese, according to the last studies performed on the prevalence of this public health problem in the U.S. During the last three decades the progress towards diminishing the burden of obesity, if any, has been minimal. What can we do Read more…
January 6, 2012 5:10 am PT by Jose Rossello, MD, PhD, MHCM - 0 comments
The National Institute of General Medical Sciences (NIGMS), a part of the National Institutes of Health that supports basic research and research training, has established two new divisions. Each will administer existing NIGMS programs along with programs transferred to NIGMS from the former NIH National Center for Research Resources (NCRR). “This reorganization will synergize and Read more…
December 31, 2011 5:34 am PT by Jose Rossello, MD, PhD, MHCM - 0 comments
Prevnar 13, a pneumococcal 13-valent conjugate vaccine, was approved today by the U.S. Food and Drug Administration for people ages 50 years and older to prevent pneumonia and invasive disease caused by the bacterium, Streptococcus pneumoniae. Pneumococcal pneumonia, caused when the bacterium Streptococcus pneumoniae infects the lungs, is the most common disease caused by this Read more…
Page [tcb_pagination_current_page] of [tcb_pagination_total_pages]